CDC42BPA and squamous cell carcinoma: MRCKα and MRCKβ are overexpressed in squamous cell carcinoma (SCC) (Nindl et al., 2006) and treatment of SCC cell lines with BDP9066 led to morphological changes and decreased bundling of filamentous actin, as well as reduced cell motility and invasion.